Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: a multicenter retrospective study

about

Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: a multicenter retrospective study

Item

http://www.wikidata.org/entity/Q57818342

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Neutrophil-to-lymphocyte ratio ...... ulticenter retrospective study

@en

Neutrophil-to-lymphocyte ratio ...... ulticenter retrospective study

@nl

type

Item

label

Neutrophil-to-lymphocyte ratio ...... ulticenter retrospective study

@en

Neutrophil-to-lymphocyte ratio ...... ulticenter retrospective study

@nl

prefLabel

Neutrophil-to-lymphocyte ratio ...... ulticenter retrospective study

@en

Neutrophil-to-lymphocyte ratio ...... ulticenter retrospective study

@nl

P1476

Neutrophil-to-lymphocyte ratio ...... ulticenter retrospective study

@en

P2093

Hironaga Satake

http://www.w3.org/2001/XMLSchema#string

Hisateru Yasui

http://www.w3.org/2001/XMLSchema#string

Kentaro Inoue

http://www.w3.org/2001/XMLSchema#string

Madoka Hamada

http://www.w3.org/2001/XMLSchema#string

Misato Ogata

http://www.w3.org/2001/XMLSchema#string

Takatsugu Ogata

http://www.w3.org/2001/XMLSchema#string

Yukimasa Hatachi

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Signatures of mutational processes in human cancer

The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer.

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade.

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.

Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.

The Neutrophil to Lymphocyte Ratio is an Independent Prognostic Factor in Patients with Metastatic Gastric Cancer.

Differential impact of the neutrophil-lymphocyte ratio on the survival of patients with stage IV gastric cancer.

P304

34520-34527

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.26145

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30349646

http://www.w3.org/2001/XMLSchema#string

P932

6195378

http://www.w3.org/2001/XMLSchema#string